These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial. Lorvand Amiri H, Agah S, Tolouei Azar J, Hosseini S, Shidfar F, Mousavi SN. Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403 [Abstract] [Full Text] [Related]
44. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats]. Zheng LY, Pan JQ, Lv JH. Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135 [Abstract] [Full Text] [Related]
45. The efficacy of sumac (Rhus coriaria L.) powder supplementation in biochemical and anthropometric measurements in overweight or obese patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial. Mohit M, Nejati M, Hejazi N, Modaresi S. Avicenna J Phytomed; 2024 Oct; 14(3):338-348. PubMed ID: 39086859 [Abstract] [Full Text] [Related]
46. [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial]. Dong C, Zhang CR, Xue BY, Miu WF, Fang NY, Li K, Ou ZJ, Xu YQ. Zhongguo Zhen Jiu; 2020 Feb 12; 40(2):129-34. PubMed ID: 32100496 [Abstract] [Full Text] [Related]
47. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial. Rusu E, Jinga M, Enache G, Rusu F, Dragomir AD, Ancuta I, Draguţ R, Parpala C, Nan R, Sima I, Ateia S, Stoica V, Cheţa DM, Radulian G. Nutr J; 2013 Aug 14; 12():119. PubMed ID: 23941362 [Abstract] [Full Text] [Related]
48. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. Moradi F, Kooshki F, Nokhostin F, Khoshbaten M, Bazyar H, Pourghassem Gargari B. J Trace Elem Med Biol; 2021 Jan 14; 63():126659. PubMed ID: 33045675 [Abstract] [Full Text] [Related]
49. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. Farhangi MA, Alipour B, Jafarvand E, Khoshbaten M. Arch Med Res; 2014 Oct 14; 45(7):589-95. PubMed ID: 25450583 [Abstract] [Full Text] [Related]
50. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Kazemi S, Shidfar F, Ehsani S, Adibi P, Janani L, Eslami O. Complement Ther Clin Pract; 2020 Nov 14; 41():101259. PubMed ID: 33190008 [Abstract] [Full Text] [Related]
51. Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Javanmardi MA, Mohammad Shahi M, Seyedian SS, Haghighizadeh MH. J Am Coll Nutr; 2018 May 16; ():1-8. PubMed ID: 29768109 [Abstract] [Full Text] [Related]
52. Petroleum ether sub-fraction of rosemary extract improves hyperlipidemia and insulin resistance by inhibiting SREBPs. Xie ZS, Zhong LJ, Wan XM, Li MN, Yang H, Li P, Xu XJ. Chin J Nat Med; 2016 Oct 16; 14(10):746-756. PubMed ID: 28236404 [Abstract] [Full Text] [Related]
53. The effect of (Cornus mas L.) fruit extract on liver function among patients with nonalcoholic fatty liver: A double-blind randomized clinical trial. Sangsefidi ZS, Yarhosseini F, Hosseinzadeh M, Ranjbar A, Akhondi-Meybodi M, Fallahzadeh H, Mozaffari-Khosravi H. Phytother Res; 2021 Sep 16; 35(9):5259-5268. PubMed ID: 34254372 [Abstract] [Full Text] [Related]
54. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Saadati S, Hatami B, Yari Z, Shahrbaf MA, Eghtesad S, Mansour A, Poustchi H, Hedayati M, Aghajanpoor-Pasha M, Sadeghi A, Hekmatdoost A. Eur J Clin Nutr; 2019 Mar 16; 73(3):441-449. PubMed ID: 30610213 [Abstract] [Full Text] [Related]
55. Impact of a low-carbohydrate and high-fiber diet on nonalcoholic fatty liver disease. Chen J, Huang Y, Xie H, Bai H, Lin G, Dong Y, Shi D, Wang J, Zhang Q, Zhang Y, Sun J. Asia Pac J Clin Nutr; 2020 Mar 16; 29(3):483-490. PubMed ID: 32990607 [Abstract] [Full Text] [Related]